Embeda FDA Approval History
FDA Approved: Yes (First approved August 13, 2009)
Brand name: Embeda
Generic name: morphine sulfate and naltrexone hydrochloride
Dosage form: Extended Release Capsules
Company: King Pharmaceuticals , Inc.
Treatment for: Pain
Embeda is an abuse-deterrent, extended-release morphine preparation for the treatment of chronic pain.
Development timeline for Embeda
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.